Aihua Liu, Ph.D.
Director of Bioanalysis, Resolian
Aihua Liu, Ph.D., brings over 15 years of experience to her role as Director of Bioanalysis at Resolian. Her research focuses on novel analytical method development/validation and its sample analysis in bioanalysis of small molecules, oligonucleotides, ADC, lipids, DBS, and others. Aihua has authored more than 65 peer-reviewed publications, abstracts, conference posters/oral presentations, and book chapters. She is an active member of the American Assoc. of Pharmaceutical Scientists (AAPS), the American Society of Mass Spectrometry (ASMS), the American Organization of Analytical Chemists (AOAC), and the Intl. Conference on the Science of Botanicals (ICSB). She has a Ph.D. in analytical chemistry from Peking University and completed four years of postdoctoral biochemistry training at the University of Utah. For more information, visit Resolian.com.
Talk to Aihua about these topics and more:
- Bioanalytical method development and validation
- High performance liquid chromatography (HPLC)
- Quality control of biological samples and medicines
- Good Laboratory Practice (GLP)
Ready to Connect?
Would you like to invite a health science expert to participate in your next piece, program, panel, or partnership? Our team is standing by to help connect you to the right source and topic:
About Resolian
Resolian (formerly Alliance Pharma Inc. and Drug Development Solutions Ltd.) is a leading global research laboratory that provides specialized services in GxP and nonregulated bioanalysis, drug metabolism/pharmacokinetics (DMPK), and GMP CMC analytical and materials science. Over 500 experts across the U.S., U.K., and Australia deliver quality results, ensuring the highest standard of regulatory compliance throughout the drug development continuum. Resolian’s dedicated laboratories are equipped with state-of-the-art technology that meet the needs of preclinical and clinical programs at any scale. Visit Resolian.com.
Save this page as a PDF
